BioCentury
ARTICLE | Clinical News

Omeprazole: Phase III data

May 24, 2004 7:00 AM UTC

Previously reported results from a Phase III trial in 359 patients showed 40 mg of Rapinex was non-inferior to intravenous cimetidine on the primary endpoint of clinically significant bleeding. In the...